Prelude Capital Management’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-400
Closed -$2K 1960
2020
Q2
$2K Sell
400
-800
-67% -$3.69K ﹤0.01% 1821
2020
Q1
$5K Buy
1,200
+400
+50% +$3.39K ﹤0.01% 1223
2019
Q4
$10K Buy
+800
New +$11.3K ﹤0.01% 1702

Other funds holding EOLS

Prelude Capital Management's EOLS Position: Q1 2026 in Review

Prelude Capital Management increased its Evolus (EOLS) stake by 31% in Q1 2026, buying an estimated $58.1K and bringing the position to 51,303 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #889.

Prelude Capital Management first reported a position in EOLS in Q1 2020 and has held it in 6 quarters since. The position peaked at $261K in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Prelude Capital Management held 51,303 shares of Evolus worth $211K as of Q1 2026.
  • Prelude Capital Management bought 12,000 Evolus shares in Q1 2026, an estimated $58.1K.
  • Evolus made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #889 holding.
  • Prelude Capital Management first reported a position in Evolus in Q1 2020 and has held it in 6 quarters since.
  • Prelude Capital Management's Evolus position peaked at $261K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.